Purchase Order 75N91024P00727

Award Date 9/23/24
Potential Completion Date 9/22/25
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Oakland, CA 94612, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for $636,976.25 and was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, a nonprofit healthcare provider and research organization. The contract is for infrastructure setup and is a delivery order under the larger "Cancer Study Cohort Recruitment" indefinite delivery/indefinite quantity (IDIQ) contract vehicle. The...
The federal contract award, with ID 75N91018D00021|75N91020F00051, was issued by the National Cancer Institute, a civilian agency, to Kaiser Foundation Hospitals, Kaiser Foundation Research Institute Division, doing business as Kaiser Permanente. This $844,110.24 delivery order award is part of a larger indefinite delivery/indefinite quantity (IDIQ) contract vehicle titled "Cancer Study Cohort Recruitment." The contract is for continued infrastructure setup and does not have a...
This federal contract, awarded by the National Cancer Institute (NCI), provides funding for a study preparation and launch effort under the larger Cancer Study Cohort Recruitment indefinite delivery/indefinite quantity (IDIQ) contract. The prime contractor is Kaiser Foundation Hospitals, a non-profit healthcare provider and research organization that is a subsidiary of Kaiser Foundation Health Plan, Inc. The $20,606,177 cost-reimbursement contract has an ultimate completion date of August 9,...
This federal contract award to Kaiser Foundation Hospitals, a division of the non-profit Kaiser Permanente healthcare system, is for biomedical research valued at $53,167,915.85. The award, made by the National Heart Lung and Blood Institute, a part of the National Institutes of Health, is a definitive contract with a cost-no-fee pricing type that runs through June 30, 2013. This contract does not have a set-aside designation. Kaiser Foundation Hospitals and its parent company, Kaiser Foundation...
This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Kaiser Foundation Hospitals, doing business as Kaiser Permanente. The $22,230.31 contract is for data queries and analysis related to outcomes after breast cancer. The award is not associated with a set-aside program. Kaiser Permanente, as a large integrated healthcare system and research organization, has a significant...
This is a $112,132.62 delivery order awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Kaiser Foundation Hospitals, doing business as Kaiser Permanente. The order is part of the larger "Cancer Study Cohort Recruitment" indefinite delivery indefinite quantity (IDIQ) contract vehicle. The task order is for information gathering and infrastructure set-up in the southern region of the United States. The work was not set aside...
This federal contract award to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, is for a Firm Fixed Price Purchase Order from the Department of Health and Human Services National Institutes of Health National Cancer Institute. The contract, valued at $249,998.00, is for a project titled "BREAST CANCER SURVIVORS COHORT LATE EFFECTS OF BREAST CANCER TREATMENTS" with a completion date of March 31, 2022. The contract has no set-aside designation. Kaiser Foundation...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $149,993 firm fixed-price purchase order to Kaiser Foundation Hospitals, Kaiser Foundation Research Institute Division, doing business as Kaiser Permanente. The contract is for the retrieval and tracking of breast tissue sample blocks to support studies of the risk of new malignancies following breast cancer. This contract is not set aside for any specific business category. Kaiser...
This federal contract award, valued at $149,884.00, was issued by the National Cancer Institute (NCI) to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, for data collection services related to treatment-related second cancers after breast cancer. The contract has a 1-year period of performance and does not have a set-aside designation. Kaiser Permanente is a large, non-profit healthcare provider and research organization that frequently partners with federal agencies like the...
This firm-fixed-price purchase order, valued at $249,999.00, was awarded by the National Cancer Institute (NCI) to the Kaiser Foundation Hospitals, Kaiser Foundation Research Institute Division, doing business as Kaiser Permanente. The contract provides for Kaiser Permanente to access electronic health data files from their Hawaii operations to assemble a cohort of female breast cancer survivors for epidemiological research. This contract supports the NCI's Radiation Epidemiology Branch and...

This federal contract award is for $15,000.00 and was issued by the National Cancer Institute (NCI) to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, for data services. The contract has an ultimate completion date of September 22, 2025 and is a firm fixed-price purchase order.

Kaiser Foundation Hospitals is a prominent non-profit healthcare provider and research organization that has extensive expertise in medical research, clinical studies, and public health initiatives. The organization has received numerous federal grants and contract awards from agencies such as the Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), and Agency for Healthcare Research and Quality (AHRQ) for projects in areas like immunization safety assessments, vaccine effectiveness studies, and epidemiological investigations.

This contract is not set aside for any specific business type, reflecting Kaiser Permanente's status as a large, established research organization capable of handling complex federal research requirements. The organization also holds several significant federal contract Indefinite Delivery Vehicles (IDVs) with the CDC and NIH, enabling it to support ongoing epidemiological and clinical research in areas like vaccine safety, cardiovascular health, and population-based health studies.

Generated 6/24/25, 9:50 AM